Optimizing epilepsy management: Seizure control, reduction, tolerability, and co-morbidities

被引:4
|
作者
Gilliam, F [1 ]
机构
[1] Washington Univ, Adult Epilepsy Ctr, St Louis, MO 63130 USA
关键词
D O I
10.1212/WNL.58.8_suppl_5.S1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S1 / S1
页数:1
相关论文
共 50 条
  • [2] Impact and Management of Co-Morbidities
    Brunelli, Alessandro
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S94 - S96
  • [3] Understanding co-morbidities affecting children with epilepsy
    Pellock, JM
    [J]. NEUROLOGY, 2004, 62 (05) : S17 - S23
  • [4] Prevention and management of co-morbidities in SLE
    Bichile, Tanmayee
    Petri, Michelle
    [J]. PRESSE MEDICALE, 2014, 43 (06): : E187 - E195
  • [5] SOMATIC CO-MORBIDITIES OF EPILEPSY: WHAT ARE THE RISK FACTORS?
    Novy, J.
    Bell, G. S.
    Sisodiya, S. M.
    Sander, J. W.
    [J]. EPILEPSIA, 2013, 54 : 275 - 276
  • [6] SOMATIC CO-MORBIDITIES ARE A MAJOR ISSUE IN PEOPLE WITH EPILEPSY
    Novy, J.
    Bell, G.
    Sisodiya, S. M.
    Sander, J. W.
    [J]. EPILEPSIA, 2012, 53 : 87 - 87
  • [7] Paediatric psoriasis: Co-morbidities and complex management
    Paller, A. S.
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2014, 55 : 7 - 7
  • [8] An update of genetics, co-morbidities and management of hyperuricaemia
    Zhu, Chunsheng
    Sun, Bao
    Zhang, Bing
    Zhou, Zheng
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2021, 48 (10) : 1305 - 1316
  • [9] Risk factors of recurrent seizure, co-morbidities, and mortality in new onset seizure in elderly
    Phabphal, Kanitpong
    Geater, Alan
    Limapichat, Kitti
    Sathirapanya, Pornchai
    Setthawatcharawanich, Suwanna
    [J]. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2013, 22 (07): : 577 - 580
  • [10] Identifying co-morbidities and risk in people with epilepsy: The Maltese experience
    Pace, Adrian
    Watkins, Lance
    Fiott, Daniel
    Bassett, Paul
    Laugharne, Richard
    James, Christopher
    Shankar, Rohit
    [J]. EPILEPSY & BEHAVIOR, 2024, 155